These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6278726)

  • 1. Evidence for control of herpes simplex virus mutagenesis by the viral DNA polymerase.
    Hall JD; Almy RE
    Virology; 1982 Jan; 116(2):535-43. PubMed ID: 6278726
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance of herpes simplex virus to acycloguanosine--genetic and physical analysis.
    Crumpacker CS; Chartrand P; Subak-Sharpe JH; Wilkie NM
    Virology; 1980 Aug; 105(1):171-84. PubMed ID: 6251603
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic mechanisms of resistance to acyclovir in herpes simplex virus.
    Crumpacker CS; Schnipper LE; Chartrand P; Knopf KW
    Am J Med; 1982 Jul; 73(1A):361-8. PubMed ID: 6285723
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversion of mutations in the thymidine kinase gene in herpes simplex viruses resistant to phosphonoacetate.
    Campione-Piccardo J; Rawls WE
    Can J Microbiol; 1984 May; 30(5):560-4. PubMed ID: 6331620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of wild-type pathogenicity to an attenuated DNA polymerase mutant of herpes simplex virus type 1.
    Larder BA; Lisle JJ; Darby G
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2501-6. PubMed ID: 3023535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance of herpes simplex virus to acycloguanosine: role of viral thymidine kinase and DNA polymerase loci.
    Schnipper LE; Crumpacker CS
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2270-3. PubMed ID: 6246532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. General aspects of virus drug resistance with special reference to herpes simplex virus.
    Coen DM
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():1-10. PubMed ID: 3025148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.
    Coen DM; Irmiere AF; Jacobson JG; Kerns KM
    Virology; 1989 Feb; 168(2):221-31. PubMed ID: 2536980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential metabolism of (E)-5-(2-bromovinyl)-2'-deoxyuridine in wild-type and drug-resistant herpes simplex virus-infected cells.
    Ayisi N; Wall R; De Clercq E; Sacks S
    Antiviral Res; 1985; Suppl 1():45-9. PubMed ID: 3002265
    [No Abstract]   [Full Text] [Related]  

  • 10. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes of herpes simplex virus types 1 and 2.
    Sauerbrei A; Bohn-Wippert K; Kaspar M; Krumbholz A; Karrasch M; Zell R
    J Antimicrob Chemother; 2016 Jan; 71(1):6-16. PubMed ID: 26433780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 12. Virus drug-resistance: mechanisms and consequences.
    Larder BA; Darby G
    Antiviral Res; 1984 Apr; 4(1-2):1-42. PubMed ID: 6331303
    [No Abstract]   [Full Text] [Related]  

  • 13. [Double recombinants of the vaccinia virus expressing hepatitis B virus surface antigen and herpes simplex virus thymidine kinase].
    Al'tshteĭn AD; Andzhaparidze OG; Antonova TP; Baev AA; Baĭsar D
    Dokl Akad Nauk SSSR; 1986; 289(6):1493-6. PubMed ID: 3021422
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex virus type 1 that exhibits herpes simplex virus type 2 sensitivity to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Docherty JJ; Dobson AT; Trimble JJ; Jennings BA
    Intervirology; 1991; 32(5):308-15. PubMed ID: 1657822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and characterisation of acyclovir-resistant herpes simplex virus type 1 mutants inducing altered DNA polymerase activities.
    Larder BA; Darby G
    Virology; 1985 Oct; 146(2):262-71. PubMed ID: 2996220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and physical evidence for the polarity of transcription of the thymidine kinase gene of herpes simplex virus.
    Smiley JR; Wagner MJ; Summers WP; Summers WC
    Virology; 1980 Apr; 102(1):83-93. PubMed ID: 6245510
    [No Abstract]   [Full Text] [Related]  

  • 17. Thymidine kinase activity of biochemically transformed mouse cells after superinfection by thymidine kinase-negative, temperature-sensitive, herpes simplex virus mutants.
    Kit S; Dubbs DR; Schaffer PA
    Virology; 1978 Apr; 85(2):456-63. PubMed ID: 208236
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity?
    Sacks SL; Wanklin RJ; Reece DE; Hicks KA; Tyler KL; Coen DM
    Ann Intern Med; 1989 Dec; 111(11):893-9. PubMed ID: 2554768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1.
    Coen DM; Schaffer PA
    Proc Natl Acad Sci U S A; 1980 Apr; 77(4):2265-9. PubMed ID: 6246531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.
    Crumpacker CS; Kowalsky PN; Oliver SA; Schnipper LE; Field AK
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1556-60. PubMed ID: 6324203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.